Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
about
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceSOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responsesUbiquitin-proteasome pathway and cellular responses to oxidative stress.Recombinant adeno-associated virus delivered human thioredoxin-PR39 prevents hypoxia-induced apoptosis of ECV304 cells.Comparison of the ventricle muscle proteome between patients with rheumatic heart disease and controls with mitral valve prolapse: HSP 60 may be a specific protein in RHD.Potential role of recombinant adeno-associated virus human thioredoxin-PR39 in cell and vascular protection against hypoxiaThe proteasome: overview of structure and functions.Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating ActivitiesNoncompetitive modulation of the proteasome by imidazoline scaffolds overcomes bortezomib resistance and delays MM tumor growth in vivo.The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.Proteasome regulators: activators and inhibitors.NADPH oxidases as therapeutic targets in ischemic stroke.Nonviral gene therapy targeting cardiovascular system.Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria.Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.Cathelicidin PR-39 peptide inhibits hypoxia/reperfusion-induced kidney cell apoptosis by suppression of the endoplasmic reticulum-stress pathway.The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs)
P2860
Q26991811-B9ED2A12-1E81-4651-A492-C6A0A016FA61Q34302552-ADEC1D2D-8700-46B4-A835-F258531E2C89Q35027877-16BE4837-F7C7-446A-BA19-261E3BC5BB49Q35139416-3620924E-FDEB-4D26-806E-F6F96FFDDAAFQ35149916-8FA4466D-D2C9-4D06-8B52-317D7D06A9D8Q35754188-A42FE48B-22DA-47A6-BDD6-95DF69F2F27EQ36472495-FD4FC74E-8225-44C3-8702-83549E530B61Q36548393-5358C15D-58C1-4EDE-90AA-61C84A0219D2Q36691554-57143C6A-481D-469A-AC8B-5C5AA2F3DF8EQ37023132-947BD8E6-0585-4652-8857-973440B4B67AQ37411350-4CB3E99F-D752-49AE-9027-2B6834553D34Q38012354-F944298A-0BA5-4E79-9F33-6CEC70982E51Q38028448-2606CDC0-CA4E-4FAE-BC97-F336A28C289EQ38241687-89F1F89F-00AD-4416-8471-26AA6116E713Q39008879-469997B7-7BE8-406D-96DA-458B3B2B6B00Q39648006-43EEB4D0-DD6C-4161-A776-EEBCF2177DA7Q41821231-E3299F86-5986-42A7-9324-3D0D68F4B4F1Q50094040-82DD2883-575D-41F4-BE3D-ACBCEAA4E716Q51743465-84F7C43B-6468-4E11-B2C5-194225128FB8Q57929840-39B3FD24-D3E7-4401-9BF8-9CC4930136A3
P2860
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@en
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@nl
type
label
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@en
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@nl
prefLabel
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@en
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@nl
P2093
P2860
P1476
Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.
@en
P2093
Asokan Anbanandam
Daniela C Tirziu
Diana C Albarado
Sudha Veeraraghavan
P2860
P304
P356
10.1016/J.JMB.2008.09.021
P407
P577
2008-09-16T00:00:00Z